Froptix Corporation's Reverse Merger Round

Froptix Corporation raised a round of funding on March 28, 2007. Investors include OPKO Health.

Froptix Corporation has licensed exclusive rights to technology developed at the University of Florida in Gainesville relating to small molecule therapeutics for retinal and macular degeneration. It h…

Articles about Froptix Corporation's Reverse Merger Round: